HTX-011 Administration Study in Planned Caesarean Section Procedure

Status:
Recruiting

Trial end date:
2021-03-01

Target enrollment:

Participant gender:

This is a Phase 2, open-label study to evaluate the PK and safety of HTX-011 in women undergoing a planned C-section.

Phase 2

Heron Therapeutics

Acetaminophen
Ibuprofen